10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $979,646 | -28.6% | 23,749 | -3.3% | 0.01% | -27.3% |
| Q2 2023 | $1,371,207 | +10.9% | 24,556 | +10.8% | 0.01% | 0.0% |
| Q1 2023 | $1,236,251 | +58.1% | 22,159 | +3.3% | 0.01% | +37.5% |
| Q4 2022 | $781,857 | +19.6% | 21,456 | -6.6% | 0.01% | +14.3% |
| Q3 2022 | $654,000 | -36.5% | 22,972 | +0.9% | 0.01% | -30.0% |
| Q2 2022 | $1,030,000 | -37.5% | 22,756 | +5.0% | 0.01% | -23.1% |
| Q1 2022 | $1,648,000 | -47.2% | 21,670 | +3.3% | 0.01% | -45.8% |
| Q4 2021 | $3,124,000 | +3.1% | 20,969 | +0.7% | 0.02% | -4.0% |
| Q3 2021 | $3,031,000 | -25.1% | 20,817 | +0.7% | 0.02% | -24.2% |
| Q2 2021 | $4,049,000 | +21.0% | 20,679 | +11.8% | 0.03% | +13.8% |
| Q1 2021 | $3,347,000 | +34.3% | 18,489 | +5.0% | 0.03% | +26.1% |
| Q4 2020 | $2,493,000 | – | 17,605 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |